Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Learn about the flu shot, COVID-19 vaccine, and our masking policy »
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Get the iPhone MyHealth app »
Get the Android MyHealth app »
PRETREATMENT URINARY MHPG LEVELS AS PREDICTORS OF ANTIDEPRESSANT RESPONSES TO ALPRAZOLAM AMERICAN JOURNAL OF PSYCHIATRY Mooney, J. J., Cole, J. O., Schatzberg, A. F., Gerson, B., Schildkraut, J. J. 1985; 142 (3): 366-367
Abstract
The authors present preliminary data showing that pretreatment levels of urinary 3-methoxy-4-hydroxyphenylglycol (MHPG) were significantly higher in six depressed patients who responded to the antidepressant effects of alprazolam than in six depressed patients who showed no antidepressant response.
View details for Web of Science ID A1985ACP3100023
View details for PubMedID 2857533